Perfil
Bo Ren Xue is the founder of ACT Genomics Co. Ltd. Mr. Xue is currently President, Chief Operating Officer & Director at AnBogen Therapeutics, Inc. since 2022.
Mr. Xue is also Vice President-Corporate Operations at TaiGen Biotechnology Co., Ltd. since 2001.
Formerly, Mr. Xue was President at AnBogen Therapeutics, Inc. Mr. Xue earned an MBA from Fairleigh Dickinson University in 1997 and completed undergraduate studies at Soochow University.
Cargos activos de Bo Ren Xue
| Empresas | Cargo | Inicio |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | Presidente | 01/05/2022 |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Director de Operaciones | 02/10/2012 |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Fundador | - |
Antiguos cargos conocidos de Bo Ren Xue.
| Empresas | Cargo | Fin |
|---|---|---|
| ANBOGEN THERAPEUTICS, INC. | Presidente | - |
Formación de Bo Ren Xue.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Fairleigh Dickinson University
Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of drugs | Health Technology |
Soochow University
Soochow University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ACT Genomics Co. Ltd.
ACT Genomics Co. Ltd. Hospital/Nursing ManagementHealth Services Provides cancer solutions | Health Services |
AnBogen Therapeutics, Inc.
AnBogen Therapeutics, Inc. BiotechnologyHealth Technology Engages in development and sale of cancer precise medical drugs | Health Technology |
- Bolsa de valores
- Insiders
- Bo Ren Xue
















